Isamu Sugiura Selected Research

Antibodies

1/2020	Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma.
9/2015	Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isamu Sugiura Research Topics

Disease

12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 12/2004
12	Philadelphia Chromosome 02/2024 - 08/2007
9	Multiple Myeloma 07/2022 - 05/2009
8	Leukemia 02/2024 - 09/2004
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 10/2007
5	Lymphoma (Lymphomas) 01/2023 - 01/2017
4	Residual Neoplasm 11/2023 - 09/2008
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2018 - 09/2015
2	Infections 01/2024 - 09/2015
2	Pathologic Complete Response 09/2008 - 01/2006
1	Febrile Neutropenia 01/2024
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 03/2021
1	Hairy Cell Leukemia 02/2021
1	Hypoprothrombinemias (Prothrombin Deficiency) 01/2020
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020
1	Hyperglycemia 03/2017
1	Colitis 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2016
1	Hepatitis 09/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2015
1	Hematoma 06/2015
1	Paralysis (Palsy) 06/2015
1	Pain (Aches) 06/2015
1	Brain Infarction 06/2015
1	Stroke (Strokes) 06/2015
1	Hypesthesia (Numbness) 06/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2010
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2008
1	Acute Promyelocytic Leukemia 03/2008
1	Lymphadenopathy 01/2006
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2006
1	Lymphocytosis 01/2006

Drug/Important Bio-Agent (IBA)

10	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 12/2004
5	Dexamethasone (Maxidex)FDA LinkGeneric 07/2022 - 10/2015
5	Rituximab (Mabthera)FDA Link 05/2022 - 03/2012
3	Tyrosine Kinase InhibitorsIBA 02/2024 - 12/2017
3	Lenalidomide (CC 5013)FDA Link 07/2022 - 03/2017
3	carfilzomibIBA 02/2021 - 03/2017
2	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 01/2016
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 01/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2021 - 10/2015
2	Etoposide (VP 16)FDA LinkGeneric 03/2021 - 01/2017
2	Antiviral Agents (Antivirals)IBA 01/2020 - 09/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2015
2	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 09/2004
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 09/2015
2	AntibodiesIBA 01/2020 - 09/2015
2	plerixafor FDA Link 11/2018 - 11/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2017 - 10/2007
2	Bortezomib (Velcade)FDA Link 01/2016 - 10/2015
2	Phosphotransferases (Kinase)IBA 05/2011 - 10/2010
1	quizartinibIBA 01/2024
1	RNA (Ribonucleic Acid)IBA 11/2023
1	daratumumabIBA 07/2022
1	pomalidomideIBA 07/2022
1	Methotrexate (Mexate)FDA LinkGeneric 05/2022
1	Vincristine (Oncovin)FDA LinkGeneric 05/2022
1	Procarbazine (Matulane)FDA Link 05/2022
1	Clofarabine (Clolar)FDA Link 03/2021
1	Bendamustine Hydrochloride FDA Link 02/2021
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2020
1	Azacitidine (5 Azacytidine)FDA Link 02/2016
1	Melphalan (Alkeran)FDA LinkGeneric 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2015
1	SteroidsIBA 09/2015
1	Hepatitis B Core AntigensIBA 09/2015
1	AnticoagulantsIBA 06/2015
1	Thalidomide (Thalomid)FDA Link 06/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2008
1	Inosine Triphosphate (ITP)IBA 04/2008
1	AnthracyclinesIBA 10/2007
1	Complementary DNA (cDNA)IBA 08/2007
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2006
1	AutoantibodiesIBA 01/2006

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2023 - 12/2004
11	Therapeutics 01/2024 - 01/2006
5	Hematopoietic Stem Cell Transplantation 05/2023 - 12/2004
3	Stem Cell Transplantation 02/2024 - 05/2009
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 05/2023 - 03/2010
2	Autologous Transplantation 11/2018 - 11/2018
1	Consolidation Chemotherapy 01/2024
1	Terminal Care (Care, Terminal) 01/2023
1	Radiotherapy 05/2022
1	EC regimen 01/2017
1	Blood Component Removal (Apheresis) 06/2015
1	Laminectomy 06/2015
1	Transplantation 03/2008
1	Induction Chemotherapy 10/2007
1	Remission Induction 01/2006